Novel bioactivation pathway of benzbromarone mediated by cytochrome P450

Yumina Kitagawara, Tomoyuki Ohe, Kumiko Tachibana, Kyoko Takahashi, Shigeo Nakamura, Tadahiko Mashino

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Benzbromarone (BBR) is a hepatotoxic drug, but the detailed mechanism of its toxicity remains unknown. We identified 2,6-dibromohydroquinone (DBH) and mono-debrominated catechol (2-ethyl-3-(3-bromo-4,5-dihydroxybenzoyl) benzofuran; CAT) as novel metabolites of BBR in rat and human liver microsomal systems by comparison with chemically synthesized authentic compounds, and we also elucidated that DBH is formed by cytochrome P450 2C9 and that CAT is formed mainly by CYP1A1, 2D6, 2E1, and 3A4. Furthermore, CAT, DBH, and the oxidized form of DBH are highly cytotoxic in HepG2 compared with BBR. Taken together, our data demonstrate that DBH, a novel reactive metabolite, may be relevant to BBR-induced hepatotoxicity.

Original languageEnglish
Pages (from-to)1303-1306
Number of pages4
JournalDrug Metabolism and Disposition
Volume43
Issue number9
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

Benzbromarone
Cytochrome P-450 Enzyme System
Cytochrome P-450 CYP1A1
Liver
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Novel bioactivation pathway of benzbromarone mediated by cytochrome P450. / Kitagawara, Yumina; Ohe, Tomoyuki; Tachibana, Kumiko; Takahashi, Kyoko; Nakamura, Shigeo; Mashino, Tadahiko.

In: Drug Metabolism and Disposition, Vol. 43, No. 9, 01.09.2015, p. 1303-1306.

Research output: Contribution to journalArticle

Kitagawara, Yumina ; Ohe, Tomoyuki ; Tachibana, Kumiko ; Takahashi, Kyoko ; Nakamura, Shigeo ; Mashino, Tadahiko. / Novel bioactivation pathway of benzbromarone mediated by cytochrome P450. In: Drug Metabolism and Disposition. 2015 ; Vol. 43, No. 9. pp. 1303-1306.
@article{a223f35fb58d4e528d7fbdfb3977af8e,
title = "Novel bioactivation pathway of benzbromarone mediated by cytochrome P450",
abstract = "Benzbromarone (BBR) is a hepatotoxic drug, but the detailed mechanism of its toxicity remains unknown. We identified 2,6-dibromohydroquinone (DBH) and mono-debrominated catechol (2-ethyl-3-(3-bromo-4,5-dihydroxybenzoyl) benzofuran; CAT) as novel metabolites of BBR in rat and human liver microsomal systems by comparison with chemically synthesized authentic compounds, and we also elucidated that DBH is formed by cytochrome P450 2C9 and that CAT is formed mainly by CYP1A1, 2D6, 2E1, and 3A4. Furthermore, CAT, DBH, and the oxidized form of DBH are highly cytotoxic in HepG2 compared with BBR. Taken together, our data demonstrate that DBH, a novel reactive metabolite, may be relevant to BBR-induced hepatotoxicity.",
author = "Yumina Kitagawara and Tomoyuki Ohe and Kumiko Tachibana and Kyoko Takahashi and Shigeo Nakamura and Tadahiko Mashino",
year = "2015",
month = "9",
day = "1",
doi = "10.1124/dmd.115.065037",
language = "English",
volume = "43",
pages = "1303--1306",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "9",

}

TY - JOUR

T1 - Novel bioactivation pathway of benzbromarone mediated by cytochrome P450

AU - Kitagawara, Yumina

AU - Ohe, Tomoyuki

AU - Tachibana, Kumiko

AU - Takahashi, Kyoko

AU - Nakamura, Shigeo

AU - Mashino, Tadahiko

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Benzbromarone (BBR) is a hepatotoxic drug, but the detailed mechanism of its toxicity remains unknown. We identified 2,6-dibromohydroquinone (DBH) and mono-debrominated catechol (2-ethyl-3-(3-bromo-4,5-dihydroxybenzoyl) benzofuran; CAT) as novel metabolites of BBR in rat and human liver microsomal systems by comparison with chemically synthesized authentic compounds, and we also elucidated that DBH is formed by cytochrome P450 2C9 and that CAT is formed mainly by CYP1A1, 2D6, 2E1, and 3A4. Furthermore, CAT, DBH, and the oxidized form of DBH are highly cytotoxic in HepG2 compared with BBR. Taken together, our data demonstrate that DBH, a novel reactive metabolite, may be relevant to BBR-induced hepatotoxicity.

AB - Benzbromarone (BBR) is a hepatotoxic drug, but the detailed mechanism of its toxicity remains unknown. We identified 2,6-dibromohydroquinone (DBH) and mono-debrominated catechol (2-ethyl-3-(3-bromo-4,5-dihydroxybenzoyl) benzofuran; CAT) as novel metabolites of BBR in rat and human liver microsomal systems by comparison with chemically synthesized authentic compounds, and we also elucidated that DBH is formed by cytochrome P450 2C9 and that CAT is formed mainly by CYP1A1, 2D6, 2E1, and 3A4. Furthermore, CAT, DBH, and the oxidized form of DBH are highly cytotoxic in HepG2 compared with BBR. Taken together, our data demonstrate that DBH, a novel reactive metabolite, may be relevant to BBR-induced hepatotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=84940385524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940385524&partnerID=8YFLogxK

U2 - 10.1124/dmd.115.065037

DO - 10.1124/dmd.115.065037

M3 - Article

C2 - 26106235

AN - SCOPUS:84940385524

VL - 43

SP - 1303

EP - 1306

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 9

ER -